The global venous stents market held a valuation of US$ 921.4 Million in 2022, and it is anticipated to expand at a CAGR of 8.4% over the forecasted years. According to a recent study by Future Market Insights, nitinol material is leading the market with a share of about 89.5% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 921.4 Million |
| Market Value 2033 | US$ 2.2 Billion |
| CAGR 2023 to 2033 | 8.4% |
| Market Share of Top 5 Countries | 52.6% |
| Key Market Players | Becton, Dickinson and Company, Cook Group Inc, Boston Scientific Corporation, Medtronic, Koninklijke Philips N.V. (Vesper Medical Inc.), Optimed Medizinische Instrumente GmbH, plus medica GmbH & Co. KG, Abbott Laboratories, Inc. |
A venous stent is a metal mesh tube that is placed inside a blocked or narrowed vein to keep it open. It acts as a scaffold to prevent the vein from collapsing and to allow blood to flow through it. Venous stenting is a minimally invasive procedure in which a fine angioplasty catheter is inserted into the affected vein. Using sophisticated imaging technology like venous ultrasound, a physician will carefully guide the angioplasty catheter to the vein's outer limits.
Venous stents are usually placed in larger, central veins such as the legs, chest, and abdomen. Stents are also used in arteries to keep them open after plaque has been removed. Venous stenting is also helpful in reduction of chronic pain, swelling, or helpful in venous ulcer healing in serious cases of existing post-thrombotic syndrome (PTS) after past deep vein thrombosis (DVT).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the venous stents are anticipated to rise at a CAGR of 8.4% between 2023 and 2033, owing to prevalence of venous diseases, adoption of minimally invasive procedures, growing ageing population, and increasing awareness about venous stents usage.
The global market holds around 8.5% share of the overall global stents market with a value of around US$ 10.8 Billion, in 2022.
The market for venous stents is increasing due to the rising prevalence of various diseases related to the venous, such as chronic venous insufficiency, deep vein thrombosis, phlebitis, varicose and spider veins, and venous stenosis. Such aforementioned disorders require venous stents for treatment purposes, and thus, the rising prevalence of venous disorders among people is driving the market.
Similarly, rising key player’s product development strategies like flexible venous stents with high radial strength are also expanding the market growth. Significant advancement has been made in the design and development of venous stents, including innovations in stent materials, design, and delivery systems. This has resulted in the development of more effective and safer stents, which will boost the demand.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 2.2 Billion during the year 2033.
Global cases of chronic cardiovascular diseases are increasing, owing to the world's growing senior population, as older people are more prone to heart-related problems.
Obesity is also a substantial global risk factor for a number of heart ailments. The excessive or incorrect deposition of fat within the arterial wall brought on by obesity can lead to coronary heart disease and other health issues. As a result, the increased obesity rate may demand several venous surgeries which indirectly aid the market growth.
The significant growth in patient base which is raising the demand for vein stent surgery is also aiding the market growth.
Principal Consultant
The restraints of the venous stents market include the high cost of venous stent procedures, lack of skilled professionals, and the risk of complications associated with venous stent implantation. The high cost of venous stent procedures is a major restraint for the growth of the venous stent market, as it limits the adoption of these procedures in developing countries. The lack of skilled professionals is also a challenge for the growth of the venous stent market, as it limits the availability of these procedures in certain regions. The risk of complications associated with venous stent implantation, such as stent migration, stent fracture, and stent thrombosis, is also a restraint for the growth of the venous stent market. The venous stent market is highly competitive, with many players operating in the development, manufacturing, and commercialization of venous stents.
The recall of numerous venous devices from the market is another factor hindering the market growth. Recently, recalls of many product was motivated by recent documentation of unanticipated unfavorable patient effects.
The USA led the global market with value share of around 32.8% in 2022 due to rising prevalence of deep vein thrombosis.
Therefore, the demand for venous stents is increasing as a result of the rising number of DVT procedures performed nationwide.
The growing healthcare expenditure in theUSA is driving demand for venous stents as more patients seek treatment for venous diseases.
Germany held market share of around 4.4% in the global market 2022 and it is expected to expand further due to high prevalence of venous diseases.
The venous stents market in Germany is primarily driven by the increasing incidence of venous diseases and disorders. These conditions often require medical intervention, including the use of venous stents, to prevent serious complications such as pulmonary embolism or venous ulcers.
China holds a market share of 6.3% in 2022 in the global market. Increased interventional cardiology and peripheral vascular operations, as well as rising acceptance of technology developments in an effort to minimize treatment duration for high-risk patients, are the primary growth factors for this market.
Chinese regulatory approvals also confirm the quality and smooth market penetration for stents. For example, National Medical Products Administration (NMPA) regulatory services include strategy, registration, type testing, product technical requirement, and check clinical evaluation report.
India held a market share of around 3.6% in the global market 2022. The venous stents market in India is expected to grow significantly in the coming years, driven by the increasing availability of venous stents from global manufacturers. Many international companies are expanding their presence in India, either through partnerships or acquisitions of local companies, to tap into the growing demand for medical devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Nitinol material is holding the market share of 89.5% in the global market 2022 because of its benefits over other materials and availability of reimbursement.
Nitinol stents are a type of self-expanding stent made from a nickel-titanium alloy that can withstand the high pressures and forces in the veins. The use of Nitinol stents has become increasingly popular in the treatment of venous diseases due to their flexibility, durability, and ability to maintain the shape of the vein after implantation. Such advantages of the product in surgical procedures are expected to drive the adoption of Nitinol stents.
Chronic Deep Vein Thrombosis (DVT) has a market share of 41.6% in the global market 2022. The prevalence of chronic DVT is increasing due to factors such as aging, obesity, sedentary lifestyles, and an increase in the number of patients undergoing surgery or cancer treatment.
Open cell stent design has a market share of 88.1% in the global market 2022. In recent years, stents have been used more frequently in the treatment of venous disorders. Open-cell stents are made up of a mesh-like structure that allows for greater flexibility and conformability to the shape of the vein. This type of stent design has larger and more widely spaced struts compared to closed-cell stents, which can improve blood flow and reduce the risk of stent migration or fracture.
One of the advantages of open-cell stent design is that it allows for better coverage of longer lesions or areas of the vein with irregular shapes. Open-cell stents can also be compressed to a smaller profile for easier delivery through narrow or tortuous vessels.
Introducer size (F) 9 has a market share of 45.4% in the global market 2022. Introducer size 9 is an important in the venous stents market. An introducer is a device that is used to insert a stent into a blood vessel. The size of the introducer is an important consideration in venous stenting procedures, as it can impact the safety and efficacy of the procedure.
Introducer size 9 refers to an introducer with an outer diameter of 9 French (3 millimeters), which is a common size used in venous stenting procedures. Its advantage is like introducer size 9 is large enough to accommodate larger stents, which can be necessary in cases where the stenosis (narrowing) in the vein is severe.
Hospitals held a market share of 34.9% in the global market 2022. Hospitals are important end users for venous stents procedures because of availability of skilled healthcare professionals, and easy adoption of advanced technology in the hospital.
Rising incidence of chronic diseases being a major factor driving this growth. While there are no specific search results for hospital trends and drivers in the venous stents market, it can be inferred that the increasing prevalence of chronic diseases and the aging population are likely to drive demand for venous stents in hospitals. The development of new and innovative venous stents is also expected to further drive market growth.
The key players in the market are actively working to improve their positions through product approvals, partnerships, acquisitions, launches, collaborations, and agreements with both existing and up-and-coming market participants. A manufacturer's chances of capturing a sizable market share significantly increases by acquisitions and partnerships.
A few examples of strategies acquired by the key players
Similarly, recent developments related to companies manufacturing venous stents have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Historical Data Available for | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the United kingdom, Germany, Italy, Russia, Spain, France, Benelux, Nordics, Poland, Hungary, Romania, Czech Republic, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia & New Zealand, Kingdom of Saudi Arabia, Northern Africa, Türkiye, GCC Countries and South Africa |
| Key Market Segments Covered | Material, Indication, Stent Design, Introducer Size, End User, and Region |
| Key Companies Profiled | Becton, Dickinson and Company; Cook Group Inc.; Boston Scientific Corporation; Medtronic; Koninklijke Philips N.V. (Vesper Medical Inc.); Optimed Medizinische Instrumente GmbH; plus medica GmbH & Co. KG; Abbott Laboratories, Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is worth US$ 921.4 Million for 2022, and is set to expand 2.4X over the next ten years.
The global market estimates for 2023 is around US$ 990.5 Million.
The global market is set to reach US$ 2.2 Billion by end of 2033.
The global market exhibited a value CAGR of 6.9% in the last 4 years.
The global market is set to expand at a CAGR of 8.4% between 2023 and 2033.
Nitinol material held a significant share of 89.5% in 2022 globally.
Hybrid stent design will expanded rapidly with at a CAGR of 11.3% between 2023 and 2033.
Rising prevalence of venous diseases, adoption of minimally invasive procedures, growing ageing population, and increasing awareness about venous stents usage are the key trends of the market.
North American region dominated the global market with USA contributing around US$ 301.9 Million in 2022
Hospitals held a market share of around 34.9% in the global market 2022.
1. Executive Summary | Venous Stents Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Product USP/Features Analysis
4.3. Regulatory Landscape, By Key Countries
4.4. Reimbursement Scenario
4.5. Recent Product Approvals/Launches
4.6. Supply Chain Analysis
4.7. Porter’s Analysis
4.8. Technological Assessment
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Stents Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. New Product Launches and Approvals
5.2.3. Epidemiology of Venous Diseases
5.2.4. Global Epidemiology of Venous Thromboembolism
5.2.5. R&D Expenditure by Key Players
5.2.6. Historic and Current Revenue of key players
5.2.7. Rising Consumer Awareness of the Product
5.2.8. Rising Adoption of Device Technological development
5.2.9. Strategic Developments by Key Players
5.2.10. Increase Adoption of Different for Venous Thromboembolism
5.2.11. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. Revenue By Material
6.1.2. Revenue By Indication
6.1.3. Revenue By Stent Design
6.1.4. Revenue by Introducer Size
6.1.5. Revenue By End User
6.1.6. Revenue By Region
6.2. 2022 Market Scenario
7. Global Market Demand (Volume in Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Material Type
8.2. Pricing Break-up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Material, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Material, 2023 to 2033
10.3.1. Nitinol
10.3.2. Elgiloy
10.4. Market Attractiveness Analysis By Material
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) By Indication, 2018 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033
11.3.1. Chronic Deep Vein Thrombosis
11.3.2. Post-Thrombotic Syndrome (PTS)
11.3.3. May-Thurner’s Syndrome (MTS)
11.3.4. Pelvic Congestion Syndrome (PCS)
11.3.5. Others
11.4. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stent Design
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) By Stent Design, 2018 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Stent Design, 2023 to 2033
12.3.1. Braided
12.3.2. Open Cell
12.3.3. Closed Cell
12.3.4. Hybrid
12.4. Market Attractiveness Analysis By Stent Design
13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Introducer Size
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) By Introducer Size, 2018 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Introducer Size, 2023 to 2033
13.3.1. Size - 6
13.3.2. Size - 7
13.3.3. Size - 8
13.3.4. Size - 9
13.3.5. Size - 10
13.4. Market Attractiveness Analysis By Introducer Size
14. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) By End User, 2018 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
14.3.1. Hospital
14.3.2. Ambulatory Surgery Centers
14.3.3. Specialty Clinics
14.3.4. Cardiac Catheterization Labs
14.4. Market Attractiveness Analysis By End User
15. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2018 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033
15.3.1. North America
15.3.2. Latin America
15.3.3. East Asia
15.3.4. South Asia & Pacific
15.3.5. Western Europe
15.3.6. Eastern Europe
15.3.7. Central Asia
15.3.8. Russia & Belarus
15.3.9. Balkan & Baltic Countries
15.3.10. Middle East and Africa
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. USA
16.3.1.2. Canada
16.3.2. By Material
16.3.3. By Indication
16.3.4. By Stent Design
16.3.5. By Introducer Size
16.3.6. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Material
16.4.3. By Indication
16.4.4. By Stent Design
16.4.5. By Introducer Size
16.4.6. By End User
16.5. Market Trends
16.6. PESTLE Analysis
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. USA Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Material
16.9.1.2.2. By Indication
16.9.1.2.3. By Stent Design
16.9.1.2.4. By Introducer Size
16.9.1.2.5. By End User
16.9.2. Canada Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Material
16.9.2.2.2. By Indication
16.9.2.2.3. By Stent Design
16.9.2.2.4. By Introducer Size
16.9.2.2.5. By End User
17. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of LATAM
17.3.2. By Material
17.3.3. By Indication
17.3.4. By Stent Design
17.3.5. By Introducer Size
17.3.6. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Material
17.4.3. By Indication
17.4.4. By Stent Design
17.4.5. By Introducer Size
17.4.6. By End User
17.5. Market Trends
17.6. PESTLE Analysis
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. Brazil Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Material
17.9.1.2.2. By Indication
17.9.1.2.3. By Stent Design
17.9.1.2.4. By Introducer Size
17.9.1.2.5. By End User
17.9.2. Mexico Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Material
17.9.2.2.2. By Indication
17.9.2.2.3. By Stent Design
17.9.2.2.4. By Introducer Size
17.9.2.2.5. By End User
17.9.3. Argentina Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Material
17.9.3.2.2. By Indication
17.9.3.2.3. By Stent Design
17.9.3.2.4. By Introducer Size
17.9.3.2.5. By End User
18. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Material
18.3.3. By Indication
18.3.4. By Stent Design
18.3.5. By Introducer Size
18.3.6. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Material
18.4.3. By Indication
18.4.4. By Stent Design
18.4.5. By Introducer Size
18.4.6. By End User
18.5. Market Trends
18.6. PESTLE Analysis
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. China Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Material
18.9.1.2.2. By Indication
18.9.1.2.3. By Stent Design
18.9.1.2.4. By Introducer Size
18.9.1.2.5. By End User
18.9.2. Japan Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Material
18.9.2.2.2. By Indication
18.9.2.2.3. By Stent Design
18.9.2.2.4. By Introducer Size
18.9.2.2.5. By End User
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Material
18.9.3.2.2. By Indication
18.9.3.2.3. By Stent Design
18.9.3.2.4. By Introducer Size
18.9.3.2.5. By End User
19. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Thailand
19.3.1.4. Philippines
19.3.1.5. Malaysia
19.3.1.6. Vietnam
19.3.1.7. Rest of ASEAN
19.3.1.8. Australia & New Zeland
19.3.2. By Material
19.3.3. By Indication
19.3.4. By Stent Design
19.3.5. By Introducer Size
19.3.6. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Material
19.4.3. By Indication
19.4.4. By Stent Design
19.4.5. By Introducer Size
19.4.6. By End User
19.5. Market Trends
19.6. PESTLE Analysis
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
19.9. Country Level Analysis & Forecast
19.9.1. India Market Analysis
19.9.1.1. Introduction
19.9.1.2. Market Analysis and Forecast by Market Taxonomy
19.9.1.2.1. By Material
19.9.1.2.2. By Indication
19.9.1.2.3. By Stent Design
19.9.1.2.4. By Introducer Size
19.9.1.2.5. By End User
19.9.2. Indonesia Market Analysis
19.9.2.1. Introduction
19.9.2.2. Market Analysis and Forecast by Market Taxonomy
19.9.2.2.1. By Material
19.9.2.2.2. By Indication
19.9.2.2.3. By Stent Design
19.9.2.2.4. By Introducer Size
19.9.2.2.5. By End User
19.9.3. Thailand Market Analysis
19.9.3.1. Introduction
19.9.3.2. Market Analysis and Forecast by Market Taxonomy
19.9.3.2.1. By Material
19.9.3.2.2. By Indication
19.9.3.2.3. By Stent Design
19.9.3.2.4. By Introducer Size
19.9.3.2.5. By End User
19.9.4. Philippines Market Analysis
19.9.4.1. Introduction
19.9.4.2. Market Analysis and Forecast by Market Taxonomy
19.9.4.2.1. By Material
19.9.4.2.2. By Indication
19.9.4.2.3. By Stent Design
19.9.4.2.4. By Introducer Size
19.9.4.2.5. By End User
19.9.5. Malaysia Market Analysis
19.9.5.1. Introduction
19.9.5.2. Market Analysis and Forecast by Market Taxonomy
19.9.5.2.1. By Material
19.9.5.2.2. By Indication
19.9.5.2.3. By Stent Design
19.9.5.2.4. By Introducer Size
19.9.5.2.5. By End User
19.9.6. Vietnam Market Analysis
19.9.6.1. Introduction
19.9.6.2. Market Analysis and Forecast by Market Taxonomy
19.9.6.2.1. By Material
19.9.6.2.2. By Indication
19.9.6.2.3. By Stent Design
19.9.6.2.4. By Introducer Size
19.9.6.2.5. By End User
19.9.7. Australia & New Zealand Market Analysis
19.9.7.1. Introduction
19.9.7.2. Market Analysis and Forecast by Market Taxonomy
19.9.7.2.1. By Material
19.9.7.2.2. By Indication
19.9.7.2.3. By Stent Design
19.9.7.2.4. By Introducer Size
19.9.7.2.5. By End User
20. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. Germany
20.3.1.2. France
20.3.1.3. Spain
20.3.1.4. Italy
20.3.1.5. BENELUX
20.3.1.6. Nordics
20.3.1.7. United Kingdom
20.3.2. By Material
20.3.3. By Indication
20.3.4. By Stent Design
20.3.5. By Introducer Size
20.3.6. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Material
20.4.3. By Indication
20.4.4. By Stent Design
20.4.5. By Introducer Size
20.4.6. By End User
20.5. Market Trends
20.6. PESTLE Analysis
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. Germany Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Material
20.9.1.2.2. By Indication
20.9.1.2.3. By Stent Design
20.9.1.2.4. By Introducer Size
20.9.1.2.5. By End User
20.9.2. France Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Material
20.9.2.2.2. By Indication
20.9.2.2.3. By Stent Design
20.9.2.2.4. By Introducer Size
20.9.2.2.5. By End User
20.9.3. Spain Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Material
20.9.3.2.2. By Indication
20.9.3.2.3. By Stent Design
20.9.3.2.4. By Introducer Size
20.9.3.2.5. By End User
20.9.4. Italy Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Material
20.9.4.2.2. By Indication
20.9.4.2.3. By Stent Design
20.9.4.2.4. By Introducer Size
20.9.4.2.5. By End User
20.9.5. BENELUX Market Analysis
20.9.5.1. Introduction
20.9.5.2. Market Analysis and Forecast by Market Taxonomy
20.9.5.2.1. By States
20.9.5.2.1.1. Belgium
20.9.5.2.1.2. Netherlands
20.9.5.2.1.3. Luxembourg
20.9.5.2.2. By Material
20.9.5.2.3. By Indication
20.9.5.2.4. By Stent Design
20.9.5.2.5. By Introducer Size
20.9.5.2.6. By End User
20.9.6. Nordic Countries Market Analysis
20.9.6.1. Introduction
20.9.6.2. Market Analysis and Forecast by Market Taxonomy
20.9.6.2.1. By States
20.9.6.2.1.1. Denmark
20.9.6.2.1.2. Norway
20.9.6.2.1.3. Sweden
20.9.6.2.1.4. Finland
20.9.6.2.1.5. Iceland
20.9.6.2.1.6. Greenland
20.9.6.2.2. By Material
20.9.6.2.3. By Indication
20.9.6.2.4. By Stent Design
20.9.6.2.5. By Introducer Size
20.9.6.2.6. By End User
20.9.7. United Kingdom Market Analysis
20.9.7.1. Introduction
20.9.7.2. Market Analysis and Forecast by Market Taxonomy
20.9.7.2.1. By Material
20.9.7.2.2. By Indication
20.9.7.2.3. By Stent Design
20.9.7.2.4. By Introducer Size
20.9.7.2.5. By End User
21. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022
21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. Poland
21.3.1.2. Hungary
21.3.1.3. Romania
21.3.1.4. Czech Republic
21.3.1.5. Others
21.3.2. By Material
21.3.3. By Indication
21.3.4. By Stent Design
21.3.5. By Introducer Size
21.3.6. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Material
21.4.3. By Indication
21.4.4. By Stent Design
21.4.5. By Introducer Size
21.4.6. By End User
21.5. Market Trends
21.6. PESTLE Analysis
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
21.9. Country Level Analysis & Forecast
21.9.1. Poland Market Analysis
21.9.1.1. Introduction
21.9.1.2. Market Analysis and Forecast by Market Taxonomy
21.9.1.2.1. By Material
21.9.1.2.2. By Indication
21.9.1.2.3. By Stent Design
21.9.1.2.4. By Introducer Size
21.9.1.2.5. By End User
21.9.2. Hungary Market Analysis
21.9.2.1. Introduction
21.9.2.2. Market Analysis and Forecast by Market Taxonomy
21.9.2.2.1. By Material
21.9.2.2.2. By Indication
21.9.2.2.3. By Stent Design
21.9.2.2.4. By Introducer Size
21.9.2.2.5. By End User
21.9.3. Romania Market Analysis
21.9.3.1. Introduction
21.9.3.2. Market Analysis and Forecast by Market Taxonomy
21.9.3.2.1. By Material
21.9.3.2.2. By Indication
21.9.3.2.3. By Stent Design
21.9.3.2.4. By Introducer Size
21.9.3.2.5. By End User
21.9.4. Czech Republic Market Analysis
21.9.4.1. Introduction
21.9.4.2. Market Analysis and Forecast by Market Taxonomy
21.9.4.2.1. By Material
21.9.4.2.2. By Indication
21.9.4.2.3. By Stent Design
21.9.4.2.4. By Introducer Size
21.9.4.2.5. By End User
22. Central Asia Market 2018 to 2022 and Forecast 2023 to 2033
22.1. Introduction
22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022
22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
22.3.1. By Material
22.3.2. By Indication
22.3.3. By Stent Design
22.3.4. By Introducer Size
22.3.5. By End User
22.4. Market Attractiveness Analysis
22.4.1. By Material
22.4.2. By Indication
22.4.3. By Stent Design
22.4.4. By Introducer Size
22.4.5. By End User
22.5. Market Trends
22.6. PESTLE Analysis
22.7. Key Market Participants - Intensity Mapping
22.8. Drivers and Restraints - Impact Analysis
23. Russia & Belarus Market 2018 to 2022 and Forecast 2023 to 2033
23.1. Introduction
23.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022
23.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
23.3.1. By Material
23.3.2. By Indication
23.3.3. By Stent Design
23.3.4. By Introducer Size
23.3.5. By End User
23.4. Market Attractiveness Analysis
23.4.1. By Material
23.4.2. By Indication
23.4.3. By Stent Design
23.4.4. By Introducer Size
23.4.5. By End User
23.5. Market Trends
23.6. PESTLE Analysis
23.7. Key Market Participants - Intensity Mapping
23.8. Drivers and Restraints - Impact Analysis
24. Balkan & Baltic Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
24.1. Introduction
24.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022
24.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
24.3.1. By Material
24.3.2. By Indication
24.3.3. By Stent Design
24.3.4. By Introducer Size
24.3.5. By End User
24.4. Market Attractiveness Analysis
24.4.1. By Material
24.4.2. By Indication
24.4.3. By Stent Design
24.4.4. By Introducer Size
24.4.5. By End User
24.5. Market Trends
24.6. PESTLE Analysis
24.7. Key Market Participants - Intensity Mapping
24.8. Drivers and Restraints - Impact Analysis
25. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
25.1. Introduction
25.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022
25.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
25.3.1. By Country
25.3.1.1. GCC Countries
25.3.1.2. Kingdom of Saudi Arabia
25.3.1.3. Türkiye
25.3.1.4. Northern Africa
25.3.1.5. South Africa
25.3.1.6. Israel
25.3.2. By Material
25.3.3. By Indication
25.3.4. By Stent Design
25.3.5. By Introducer Size
25.3.6. By End User
25.4. Market Attractiveness Analysis
25.4.1. By Country
25.4.2. By Material
25.4.3. By Indication
25.4.4. By Stent Design
25.4.5. By Introducer Size
25.4.6. By End User
25.5. Market Trends
25.6. PESTLE Analysis
25.7. Key Market Participants - Intensity Mapping
25.8. Drivers and Restraints - Impact Analysis
25.9. Country Level Analysis & Forecast
25.9.1. GCC Countries Market Analysis
25.9.1.1. Introduction
25.9.1.2. Market Analysis and Forecast by Market Taxonomy
25.9.1.2.1. By Material
25.9.1.2.2. By Indication
25.9.1.2.3. By Stent Design
25.9.1.2.4. By Introducer Size
25.9.1.2.5. By End User
25.9.2. Kingdom of Saudi Arabia Market Analysis
25.9.2.1. Introduction
25.9.2.2. Market Analysis and Forecast by Market Taxonomy
25.9.2.2.1. By Material
25.9.2.2.2. By Indication
25.9.2.2.3. By Stent Design
25.9.2.2.4. By Introducer Size
25.9.2.2.5. By End User
25.9.3. Türkiye Market Analysis
25.9.3.1. Introduction
25.9.3.2. Market Analysis and Forecast by Market Taxonomy
25.9.3.2.1. By Material
25.9.3.2.2. By Indication
25.9.3.2.3. By Stent Design
25.9.3.2.4. By Introducer Size
25.9.3.2.5. By End User
25.9.4. Northern Africa Market Analysis
25.9.4.1. Introduction
25.9.4.2. Market Analysis and Forecast by Market Taxonomy
25.9.4.2.1. By Material
25.9.4.2.2. By Indication
25.9.4.2.3. By Stent Design
25.9.4.2.4. By Introducer Size
25.9.4.2.5. By End User
25.9.5. South Africa Market Analysis
25.9.5.1. Introduction
25.9.5.2. Market Analysis and Forecast by Market Taxonomy
25.9.5.2.1. By Material
25.9.5.2.2. By Indication
25.9.5.2.3. By Stent Design
25.9.5.2.4. By Introducer Size
25.9.5.2.5. By End User
25.9.6. Israel Market Analysis
25.9.6.1. Introduction
25.9.6.2. Market Analysis and Forecast by Market Taxonomy
25.9.6.2.1. By Material
25.9.6.2.2. By Indication
25.9.6.2.3. By Stent Design
25.9.6.2.4. By Introducer Size
25.9.6.2.5. By End User
26. Market Structure Analysis
26.1. Market Analysis by Tier of Companies
26.2. Market Share Analysis of Top Players (%)
26.3. Market Presence Analysis
26.3.1. By Regional Footprint of Players
26.3.2. Product Footprint of Players
26.3.3. Channel Footprint of Players
27. Competition Analysis
27.1. Competition Dashboard
27.2. Competition Benchmarking
27.3. Competition Deep Dive
27.3.1. Becton, Dickinson and Company
27.3.1.1. Overview
27.3.1.2. Product Portfolio
27.3.1.3. Key Financials
27.3.1.4. SWOT Analysis
27.3.1.5. Key Developments
27.3.1.6. Sales Footprint
27.3.1.7. Strategy Overview
27.3.1.7.1. Marketing Strategies
27.3.1.7.2. Product Strategies
27.3.1.7.3. Channel Strategies
27.3.2. Cook Group Inc
27.3.2.1. Overview
27.3.2.2. Product Portfolio
27.3.2.3. Key Financials
27.3.2.4. SWOT Analysis
27.3.2.5. Key Developments
27.3.2.6. Sales Footprint
27.3.2.7. Strategy Overview
27.3.2.7.1. Marketing Strategies
27.3.2.7.2. Product Strategies
27.3.2.7.3. Channel Strategies
27.3.3. Boston Scientific Corporation
27.3.3.1. Overview
27.3.3.2. Product Portfolio
27.3.3.3. Key Financials
27.3.3.4. SWOT Analysis
27.3.3.5. Key Developments
27.3.3.6. Sales Footprint
27.3.3.7. Strategy Overview
27.3.3.7.1. Marketing Strategies
27.3.3.7.2. Product Strategies
27.3.3.7.3. Channel Strategies
27.3.4. Medtronic
27.3.4.1. Overview
27.3.4.2. Product Portfolio
27.3.4.3. Key Financials
27.3.4.4. SWOT Analysis
27.3.4.5. Key Developments
27.3.4.6. Sales Footprint
27.3.4.7. Strategy Overview
27.3.4.7.1. Marketing Strategies
27.3.4.7.2. Product Strategies
27.3.4.7.3. Channel Strategies
27.3.5. Koninklijke Philips N.V. (Vesper Medical Inc.)
27.3.5.1. Overview
27.3.5.2. Product Portfolio
27.3.5.3. Key Financials
27.3.5.4. SWOT Analysis
27.3.5.5. Key Developments
27.3.5.6. Sales Footprint
27.3.5.7. Strategy Overview
27.3.5.7.1. Marketing Strategies
27.3.5.7.2. Product Strategies
27.3.5.7.3. Channel Strategies
27.3.6. Optimed Medizinische Instrumente GmbH
27.3.6.1. Overview
27.3.6.2. Product Portfolio
27.3.6.3. Key Financials
27.3.6.4. SWOT Analysis
27.3.6.5. Key Developments
27.3.6.6. Sales Footprint
27.3.6.7. Strategy Overview
27.3.6.7.1. Marketing Strategies
27.3.6.7.2. Product Strategies
27.3.6.7.3. Channel Strategies
27.3.7. plus medica GmbH & Co. KG
27.3.7.1. Overview
27.3.7.2. Product Portfolio
27.3.7.3. Key Financials
27.3.7.4. SWOT Analysis
27.3.7.5. Key Developments
27.3.7.6. Sales Footprint
27.3.7.7. Strategy Overview
27.3.7.7.1. Marketing Strategies
27.3.7.7.2. Product Strategies
27.3.7.7.3. Channel Strategies
27.3.8. Abbott Laboratories, Inc.
27.3.8.1. Overview
27.3.8.2. Product Portfolio
27.3.8.3. Key Financials
27.3.8.4. SWOT Analysis
27.3.8.5. Key Developments
27.3.8.6. Sales Footprint
27.3.8.7. Strategy Overview
27.3.8.7.1. Marketing Strategies
27.3.8.7.2. Product Strategies
27.3.8.7.3. Channel Strategies
28. Assumptions and Acronyms Used
29. Research Methodolog
Explore Healthcare Insights
View Reports
Venous Stents Market
